151 related articles for article (PubMed ID: 25332611)
1. Coexistence of JAK2V617F Mutation and BCR-ABL Translocation in a Pregnant Woman with Essential Thrombocythemia.
Qin YW; Yang YN; Li S; Wang C
Indian J Hematol Blood Transfus; 2014 Sep; 30(Suppl 1):331-4. PubMed ID: 25332611
[TBL] [Abstract][Full Text] [Related]
2. Concomitant presence of JAK2 V617F mutation and BCR-ABL translocation in a pregnant woman with polycythemia vera.
Toogeh G; Ferdowsi S; Naadali F; Alimoghaddam K; Ghavamzadeh A; Shirkoohi R; Ghaffari SH
Med Oncol; 2011 Dec; 28(4):1555-8. PubMed ID: 20499211
[TBL] [Abstract][Full Text] [Related]
3. [Atypical myeloproliferative neoplasm with a small population of Philadelphia chromosome-positive clones in the bone marrow].
Takai K; Ushiki T; Nikkuni K; Hashidate H; Shibuya H
Rinsho Ketsueki; 2011 Feb; 52(2):73-7. PubMed ID: 21403427
[TBL] [Abstract][Full Text] [Related]
4. Concomitant BCR-ABL1 translocation and JAK2(V617F) mutation in three patients with myeloproliferative neoplasms.
Hummel JM; Kletecka MC; Sanks JK; Chiselite MD; Roulston D; Smith LB; Czuchlewski DR; Elenitoba-Johnson KS; Lim MS
Diagn Mol Pathol; 2012 Sep; 21(3):176-83. PubMed ID: 22847163
[TBL] [Abstract][Full Text] [Related]
5. Coexistence of breakpoint cluster region-Abelson1 rearrangement and Janus kinase 2 V617F mutation in chronic myeloid leukemia: A case report.
Shi XB; Jiang JF; Jin FX; Cheng W
World J Clin Cases; 2019 May; 7(9):1087-1092. PubMed ID: 31123683
[TBL] [Abstract][Full Text] [Related]
6. A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias.
Cox MC; Maffei L; Buffolino S; Del Poeta G; Venditti A; Cantonetti M; Aronica G; Aquilina P; Masi M; Amadori S
Am J Clin Pathol; 1998 Jan; 109(1):24-31. PubMed ID: 9426514
[TBL] [Abstract][Full Text] [Related]
7.
Zhang Y; Bi H; Wang Y; Chen L; Pan J; Xu P; Wang W; Yang S
Blood Sci; 2022 Oct; 4(4):199-204. PubMed ID: 36518237
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.
Tbakhi A; Pettay J; Sreenan JJ; Abdel-Razeq H; Kalaycio M; Hoeltge G; Miller ML; Tubbs RR
Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513
[TBL] [Abstract][Full Text] [Related]
9. Chronic myeloid leukemia patient with co-occurrence of BCR-ABL junction and JAK2 V617F mutation.
Xu W; Chen B; Tong X
Int J Hematol; 2014 Jan; 99(1):87-90. PubMed ID: 24293258
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of Qualitative Testing of BCR-ABL and JAK2 V617F in Suspected Myeloproliperative Neoplasm (MPN) Using RT-PCR Reversed Dot Blot Hybridization (RT-PCR RDB).
Masykura N; Habibah U; Selasih SF; Gani S; Irawan C; Somoastro S; Handoyo Utomo AR
Clin Lymphoma Myeloma Leuk; 2019 Apr; 19(4):220-227. PubMed ID: 30772299
[TBL] [Abstract][Full Text] [Related]
11. BCR-ABL and JAK2V617F Mutation Co-existence, Rare or Just Unexplored.
Darling HS; Kumar R; Kapoor R; Singh J; Verma T
Indian J Hematol Blood Transfus; 2017 Dec; 33(4):633-635. PubMed ID: 29075087
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of CALR, JAK2 and MPL gene mutations in BCR-ABL negative myeloproliferative neoplasms].
Ouyang Y; Qiao C; Wang J; Xiao L; Zhang S
Zhonghua Yi Xue Za Zhi; 2015 May; 95(18):1369-73. PubMed ID: 26178351
[TBL] [Abstract][Full Text] [Related]
13. Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11).
Mundhada S; Luthra R; Cano P
BMC Cancer; 2004 Jun; 4():25. PubMed ID: 15202948
[TBL] [Abstract][Full Text] [Related]
14. Concomitant essential thrombocythemia with JAK2 V617F mutation in a patient with chronic myeloid leukemia with major molecular response with imatinib and long-term follow-up.
Pagnano KB; Delamain MT; Magnus MM; Vassallo J; DE Souza CA; DE Almeida D; Lorand-Metze I
Oncol Lett; 2016 Jul; 12(1):485-487. PubMed ID: 27347169
[TBL] [Abstract][Full Text] [Related]
15. Coexistence of p190 BCR/ABL Transcript and CALR 52-bp Deletion in Chronic Myeloid Leukemia Blast Crisis: A Case Report.
Seghatoleslami M; Ketabchi N; Ordo A; Asl JM; Golchin N; Saki N
Mediterr J Hematol Infect Dis; 2016; 8(1):e2016002. PubMed ID: 26740863
[TBL] [Abstract][Full Text] [Related]
16. Phospho-STAT5 expression pattern with the MPL W515L mutation is similar to that seen in chronic myeloproliferative disorders with JAK2 V617F.
Gibson SE; Schade AE; Szpurka H; Bak B; Maciejewski JP; Hsi ED
Hum Pathol; 2008 Jul; 39(7):1111-4. PubMed ID: 18479730
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].
Schwarz J; Penka M; Campr V; Pospísilová D; Kren L; Nováková L; Bodzásová C; Brychtová Y; Cerná O; Dulícek P; Joniásová A; Kissová J; Korístek Z; Schützová M; Vonke I; Walterová L
Vnitr Lek; 2011 Feb; 57(2):189-213. PubMed ID: 21416861
[TBL] [Abstract][Full Text] [Related]
18. Complex chromosome 9, 20, and 22 rearrangements in acute lymphoblastic leukemia with duplication of BCR and ABL sequences.
Stevens-Kroef MJ; Dirckx R; Meers LE; Albrechts JC; Schouten HC; Hamers AJ
Cancer Genet Cytogenet; 2000 Jan; 116(2):119-23. PubMed ID: 10640143
[TBL] [Abstract][Full Text] [Related]
19. Concomitant presence of JAK2V617F mutation and BCR‑ABL translocation in two patients: A new entity or a variant of myeloproliferative neoplasms (Case report).
Mousinho F; Azevedo AP; Mendes T; Santos PSE; Cerqueira R; Matos S; Santos S; Ramos S; Viana JF; Lima F
Mol Med Rep; 2018 Jul; 18(1):1001-1006. PubMed ID: 29845291
[TBL] [Abstract][Full Text] [Related]
20. A novel tricolor, dual-fusion fluorescence in situ hybridization method to detect BCR/ABL fusion in cells with t(9;22)(q34;q11.2) associated with deletion of DNA on the derivative chromosome 9 in chronic myelocytic leukemia.
Smoley SA; Brockman SR; Paternoster SF; Meyer RG; Dewald GW
Cancer Genet Cytogenet; 2004 Jan; 148(1):1-6. PubMed ID: 14697634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
